Thursday, 8 May 2014

Taking Stock of Human Cell Therapies

Positive results in human cell therapy trials are now making the news and this conference will feature a fascinating discussion about the governance challenges and commercial opportunities these therapies present. Panellists from academia and industry will take stock of the perception and reality of the new technologies, in terms of investor readiness, regulatory streamlining and the pragmatic validation of new therapies and drug testing methods. There will be audience participation in this session with an opportunity to add your opinion to the debate.